vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and ROGERS COMMUNICATIONS INC (RCI). Click either name above to swap in a different company.

ROGERS COMMUNICATIONS INC is the larger business by last-quarter revenue ($978.2M vs $749.2M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Rogers Communications Inc. is a Canadian communications and media company operating primarily in the fields of wireless communications, cable television, telephony and Internet, with significant additional telecommunications, mass media, and professional sports assets. Rogers has its headquarters in Toronto, Ontario.

CLOV vs RCI — Head-to-Head

Bigger by revenue
RCI
RCI
1.3× larger
RCI
$978.2M
$749.2M
CLOV

Income Statement — Q1 FY2026 vs Q1 FY2023

Metric
CLOV
CLOV
RCI
RCI
Revenue
$749.2M
$978.2M
Net Profit
$27.3M
Gross Margin
Operating Margin
3.6%
Net Margin
3.6%
Revenue YoY
62.0%
Net Profit YoY
EPS (diluted)
$0.05
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
RCI
RCI
Q1 26
$749.2M
Q4 25
$487.7M
Q3 25
$496.6M
Q2 25
$477.6M
Q1 25
$462.3M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
Net Profit
CLOV
CLOV
RCI
RCI
Q1 26
$27.3M
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Gross Margin
CLOV
CLOV
RCI
RCI
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
RCI
RCI
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Net Margin
CLOV
CLOV
RCI
RCI
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
EPS (diluted)
CLOV
CLOV
RCI
RCI
Q1 26
$0.05
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
RCI
RCI
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
Total Assets
$697.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
RCI
RCI
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Stockholders' Equity
CLOV
CLOV
RCI
RCI
Q1 26
$339.4M
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Total Assets
CLOV
CLOV
RCI
RCI
Q1 26
$697.7M
Q4 25
$541.0M
Q3 25
$559.7M
Q2 25
$575.0M
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons